Clinical trial
Treatment of Suicidal Ideation With Intravenous Ketamine Infusion
NCT01887990 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Suicidal Ideation With Intravenous Ketamine Infusion
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- January 31, 2014
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression, suicidal ideation